Published in J Clin Psychiatry on December 01, 1993
Sex differences in anxiety and depression clinical perspectives. Front Neuroendocrinol (2014) 1.23
Variant brain-derived neurotrophic factor (Valine66Methionine) polymorphism contributes to developmental and estrous stage-specific expression of anxiety-like behavior in female mice. Biol Psychiatry (2012) 1.05
Panic disorder and pregnancy. J Clin Psychiatry (1995) 0.75
Anxiety Disorders Among Women: A Female Lifespan Approach. Focus (Am Psychiatr Publ) (2017) 0.75
The epidemiology of co-occurring addictive and mental disorders: implications for prevention and service utilization. Am J Orthopsychiatry (1996) 4.93
The prevalence and correlates of untreated serious mental illness. Health Serv Res (2001) 4.87
Utilization of health and mental health services. Three Epidemiologic Catchment Area sites. Arch Gen Psychiatry (1984) 3.55
Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: A randomized controlled trial. JAMA (2000) 3.52
Multicenter collaborative panic disorder severity scale. Am J Psychiatry (1997) 3.29
Symptom assessment in schizophrenic prodromal states. Psychiatr Q (1999) 3.09
Contact with health professionals for the treatment of psychiatric and emotional problems. Med Care (1985) 2.53
The NIMH Methods for the Epidemiology of Child and Adolescent Mental Disorders (MECA) Study: background and methodology. J Am Acad Child Adolesc Psychiatry (1996) 2.43
Reliability of the services assessment for children and adolescents. Psychiatr Serv (2001) 2.41
Psychiatric status and 9-year mortality data in the New Haven Epidemiologic Catchment Area Study. Am J Psychiatry (1994) 2.39
Poverty and psychiatric status. Longitudinal evidence from the New Haven Epidemiologic Catchment Area study. Arch Gen Psychiatry (1991) 2.35
Six-month prevalence of psychiatric disorders in three communities 1980 to 1982. Arch Gen Psychiatry (1984) 2.26
How can epidemiology improve mental health services for children and adolescents? J Am Acad Child Adolesc Psychiatry (1993) 2.22
Fear-potentiated startle in humans: effects of anticipatory anxiety on the acoustic blink reflex. Psychophysiology (1991) 1.95
The prevalence of major depression in black and white adults in five United States communities. Am J Epidemiol (1989) 1.95
Mental health in pediatric settings: distribution of disorders and factors related to service use. J Am Acad Child Adolesc Psychiatry (2000) 1.88
Affective disorders in five United States communities. Psychol Med (1988) 1.78
Racial differences in attitudes toward professional mental health care and in the use of services. Am J Orthopsychiatry (2000) 1.75
The NIfETy method for environmental assessment of neighborhood-level indicators of violence, alcohol, and other drug exposure. Prev Sci (2008) 1.74
The relationship between panic disorder and major depression. A new family study. Arch Gen Psychiatry (1993) 1.59
The relationship between demographic factors and attitudes toward mental health services. J Community Psychol (1987) 1.55
Identification of violence in the home: pediatric and parental reports. Arch Pediatr Adolesc Med (2000) 1.55
Pre-onset detection and intervention research in schizophrenia psychoses: current estimates of benefit and risk. Schizophr Bull (2001) 1.53
Co-morbidity and familial aggregation of alcoholism and anxiety disorders. Psychol Med (1998) 1.52
Measurement of risk for mental disorders and competence in a psychiatric epidemiologic community survey: the National Institute of Mental Health Methods for the Epidemiology of Child and Adolescent Mental Disorders (MECA) Study. Soc Psychiatry Psychiatr Epidemiol (1998) 1.50
Baseline and fear-potentiated startle in panic disorder patients. Biol Psychiatry (1994) 1.49
Clinical and medication outcome after short-term alprazolam and behavioral group treatment in panic disorder. 2.5 year naturalistic follow-up study. Arch Gen Psychiatry (1989) 1.47
Factorial structure of the Scale of Prodromal Symptoms. Schizophr Res (2004) 1.47
The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. I. Study rationale and design. Schizophr Res (2003) 1.47
Identification and management of psychosocial and developmental problems in community-based, primary care pediatric practices. Pediatrics (1992) 1.46
Neuropsychological status of subjects at high risk for a first episode of psychosis. Schizophr Res (2004) 1.42
Influence of comorbid alcohol and psychiatric disorders on utilization of mental health services in the National Comorbidity Survey. Am J Psychiatry (1999) 1.39
The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. II. Baseline characteristics of the "prodromal" sample. Schizophr Res (2003) 1.29
Psychiatric disorders and 15-month mortality in a community sample of older adults. Am J Public Health (1989) 1.29
The epidemiology of depression. An update on sex differences in rates. J Affect Disord (1984) 1.27
Ambulatory visit groups: an outpatient classification system. J Ambul Care Manage (1988) 1.25
Use of the Medication Event Monitoring System to estimate medication compliance in patients with schizophrenia. J Psychiatry Neurosci (2001) 1.20
Homelessness and drug abuse in New Haven. Hosp Community Psychiatry (1992) 1.20
Olanzapine and tardive dyskinesia. Br J Psychiatry (1999) 1.19
The child vulnerability scale: an instrument to measure parental perceptions of child vulnerability. J Pediatr Psychol (1996) 1.16
Depressive episodes and dysphoria resulting from conjugal bereavement in a prospective community sample. Am J Psychiatry (1990) 1.16
The epidemiology of dysthymia in five communities: rates, risks, comorbidity, and treatment. Am J Psychiatry (1988) 1.16
Attenuated psychosis syndrome: ready for DSM-5.1? Annu Rev Clin Psychol (2014) 1.14
Behavioral, physiological, and pharmacological interaction of cocaine and disulfiram in humans. Biol Psychiatry (1995) 1.13
Measuring the time course of anticipatory anxiety using the fear-potentiated startle reflex. Psychophysiology (1993) 1.08
Identification of psychosocial problems in pediatric primary care: do family attitudes make a difference? Arch Pediatr Adolesc Med (1998) 1.07
Psychopathology and mortality in the general population. Soc Psychiatry Psychiatr Epidemiol (1995) 1.07
A historical review of the Madison model of community care. Hosp Community Psychiatry (1990) 1.06
Pretreatment patient factors predicting attrition from a multicenter randomized controlled treatment study for panic disorder. Compr Psychiatry (1999) 1.06
Therapists, therapist variables, and cognitive-behavioral therapy outcome in a multicenter trial for panic disorder. J Consult Clin Psychol (2001) 1.03
Reliability of self-reported age at onset of major depression. J Psychiatr Res (1989) 1.02
Carbon dioxide sensitivity in panic anxiety. Ventilatory and anxiogenic response to carbon dioxide in healthy subjects and patients with panic anxiety before and after alprazolam treatment. Arch Gen Psychiatry (1986) 1.02
Performance of subcutaneously implanted needle-type glucose sensors employing a novel trilayer coating. Anal Chem (1993) 1.02
Age, period and cohort effects on the risk of major depression: results from five United States communities. J Clin Epidemiol (1989) 1.01
Linkage genome scan for loci predisposing to panic disorder or agoraphobia. Am J Med Genet (2001) 1.01
Temporal lobe volume in panic disorder--a quantitative magnetic resonance imaging study. Psychiatry Res (2000) 1.01
Receptor binding characterization of the benzodiazepine radioligand 125I-Ro16-0154: potential probe for SPECT brain imaging. Life Sci (1990) 1.01
Effects of clozapine on smoking in chronic schizophrenic outpatients. J Clin Psychiatry (1995) 1.00
Pretreatment attrition in a comparative treatment outcome study on panic disorder. Am J Psychiatry (1998) 0.98
Gender differences in the use of mental health-related services: a re-examination. J Health Soc Behav (1987) 0.97
Noradrenergic neuronal dysregulation in panic disorder: the effects of intravenous yohimbine and clonidine in panic disorder patients. Acta Psychiatr Scand (1992) 0.96
The differential effect of attitudes on the use of mental health services. Soc Psychiatry (1986) 0.96
Neurobiological mechanisms of panic anxiety: biochemical and behavioral correlates of yohimbine-induced panic attacks. Am J Psychiatry (1987) 0.95
Catatonia in a patient with subdural hematomas. Am J Psychiatry (1980) 0.94
Applicants' choice of a residency training program. Am J Psychiatry (1987) 0.93
Effect of catecholamine depletion on lithium-induced long-term remission of bipolar disorder. Biol Psychiatry (1999) 0.93
Psychiatric disorders (DSM-III) and cognitive impairment among the elderly in a U.S. urban community. Acta Psychiatr Scand (1985) 0.92
Early coadministration of clonazepam with sertraline for panic disorder. Arch Gen Psychiatry (2001) 0.92
Chronic neuroleptic use in manic-depressive illness. Psychopharmacol Bull (1993) 0.91
Psychiatric disorders in relatives of probands with panic disorder and/or major depression. Arch Gen Psychiatry (1994) 0.91
The effects of cognitive impairment on 9-year mortality in a community sample. J Gerontol B Psychol Sci Soc Sci (1995) 0.90
Serotonin function in obsessive-compulsive disorder. A comparison of the effects of tryptophan and m-chlorophenylpiperazine in patients and healthy subjects. Arch Gen Psychiatry (1988) 0.90
Effects of panic disorder treatments on personality disorder characteristics. Depress Anxiety (1998) 0.90
Psychostimulant treatment of depressive disorders secondary to medical illness. J Clin Psychiatry (1986) 0.90
Acute cocaine effects on absolute cerebral blood flow. Psychopharmacology (Berl) (1996) 0.89
Characteristics of youths identified from a psychiatric case register as first-time users of services. Hosp Community Psychiatry (1993) 0.89
Serotonin function and human anxiety disorders. Ann N Y Acad Sci (1990) 0.87
Fluvoxamine in the treatment of panic disorder: a multi-center, double-blind, placebo-controlled study in outpatients. Psychiatry Res (2001) 0.86
Single parent women. A community study. Soc Psychiatry (1987) 0.86
Social functioning in community residents with depression and other psychiatric disorders: results of the New Haven Epidemiologic Catchment Area Study. J Affect Disord (1989) 0.86
A national study of psychiatrists' professional activities. Am J Psychiatry (1992) 0.86
Relation of age of onset to the type and severity of child and adolescent conduct problems. J Abnorm Child Psychol (1999) 0.85
Endothelial nitric oxide synthase increases in left atria of dogs with pacing-induced heart failure. Am J Physiol (1998) 0.85
Teacher assessments of children's behavioral disorders: demographic correlates. Am J Orthopsychiatry (1998) 0.85
Regional cerebral blood flow during acute and chronic abstinence from combined cocaine-alcohol abuse. Drug Alcohol Depend (1998) 0.85
Serotonin function in anxiety. II. Effects of the serotonin agonist MCPP in panic disorder patients and healthy subjects. Psychopharmacology (Berl) (1987) 0.84
A chromosome 14 risk locus for simple phobia: results from a genomewide linkage scan. Mol Psychiatry (2003) 0.84
Naltrexone augmentation of neuroleptics in schizophrenia. J Clin Psychopharmacol (1998) 0.84
Reliability of sequential naloxone challenge tests. Am J Drug Alcohol Abuse (1995) 0.84
Responses of children with different intake profiles to mental health treatment. Psychiatr Serv (2001) 0.84
Dynamic SPECT imaging of dopamine D2 receptors in human subjects with iodine-123-IBZM. J Nucl Med (1992) 0.84
Situational panic attacks. Behavioral, physiologic, and biochemical characterization. Arch Gen Psychiatry (1987) 0.84
Suicide attempts in the "comprehensive community mental health services for children and their families" program. J Am Acad Child Adolesc Psychiatry (2001) 0.83
A pilot study of dextromethorphan in naloxone-precipitated opiate withdrawal. Eur J Pharmacol (1996) 0.83
Discriminative stimulus, self-reported and cardiovascular effects of orally administered cocaine in humans. J Pharmacol Exp Ther (1995) 0.82
Effects of tryptophan depletion on responses to yohimbine in healthy human subjects. Biol Psychiatry (1995) 0.82
Buprenorphine: duration of blockade of effects of intramuscular hydromorphone. Drug Alcohol Depend (1994) 0.82
Drug treatment of panic disorder: the comparative efficacy of imipramine, alprazolam, and trazodone. J Clin Psychiatry (1986) 0.82
m-Chlorophenylpiperazine effects in neuroleptic-free schizophrenic patients. Evidence implicating serotonergic systems in the positive symptoms of schizophrenia. Arch Gen Psychiatry (1993) 0.82